Cardioplegia Solution Recall Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling cardioplegia solution due to lack of assurance of sterility. An FDA inspection raised concerns about whether the 329 bags were properly sterilized.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA classified this as a Class II recall. No illnesses or injuries have been reported in the source material. Per the severity rubric, a Class II recall without reported hospitalization or adverse events, where the sterility concern is theoretical, scores as High (3).
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 329 bags of Cardioplegia Solution, Modified St Thomas Formula (HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL bags, NDC 71285-0209-1, Rx only) due to lack of assurance of sterility. An FDA inspection raised questions about whether these products, which are intended to be sterile, were properly sterilized.
The affected product was distributed nationwide in the USA under the following lot numbers: 37-893789 (Exp 04/28/2023), 37-894318 (Exp 04/29/2023), 37-895648 (Exp 05/05/2023), 37-897301 (Exp 05/12/2023), and 37-898815 (Exp 05/18/2023).
Healthcare providers and patients should not use the recalled product without contacting the manufacturer or their healthcare provider. Those with questions should contact Central Admixture Pharmacy Services, Inc. in Allentown, PA for additional information.
The recalled product
- Product
- Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0209-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Sterile Injectable
- Hazard
- sterilization-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 37-893789
- Exp 04/28/2023
- 37-894318
- Exp 04/29/2023
- 37-895648
- Exp 05/05/2023
- 37-897301
- Exp 05/12/2023
- 37-898815
- Exp 05/18/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27